SG11201909016TA - Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety - Google Patents

Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety

Info

Publication number
SG11201909016TA
SG11201909016TA SG11201909016TA SG11201909016TA SG 11201909016T A SG11201909016T A SG 11201909016TA SG 11201909016T A SG11201909016T A SG 11201909016TA SG 11201909016T A SG11201909016T A SG 11201909016TA
Authority
SG
Singapore
Prior art keywords
international
california
tiger
carlsbad
suite
Prior art date
Application number
Inventor
Michael P Bevilacqua
Daniel J Huang
Doug Looker
Original Assignee
Amicrobe Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amicrobe Inc filed Critical Amicrobe Inc
Publication of SG11201909016TA publication Critical patent/SG11201909016TA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/25—Peptides having up to 20 amino acids in a defined sequence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 11 October 2018 (11.10.2018) WIPO I PCT omit °nolo moimm mum° oimIE (10) International Publication Number WO 2018/187617 Al (51) International Patent Classification: A61K 38/00 (2006.01) A61K 9/08 (2006.01) A61K 38/16 (2006.01) A61P 31/04 (2006.01) (21) International Application Number: PCT/US2018/026322 (22) International Filing Date: 05 April 2018 (05.04.2018) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/482,630 06 April 2017 (06.04.2017) US (71) Applicant: AMICROBE, INC. [US/US]; 3142 Tiger Run Court, Suite 101, Carlsbad, California 92010 (US). (72) Inventors: BEVILACQUA, Michael P.; 3142 Tiger Run Court, Suite 101, Carlsbad, California 92010 (US). HUANG, Daniel J.; 3142 Tiger Run Court, Suite 101, Carlsbad, California 92010 (US). LOOKER, Doug; 3142 Tiger Run Court, Suite 101, Carlsbad, California 92010 (US). (74) Agent: MALLON, Joseph J.; Knobbe, Martens, Olson & Bear LLP, 2040 Main Street 14th Floor, Irvine, California 92614 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, (54) Title: COMPOSITIONS AND USES OF LOCALLY APPLIED ANTIMICROBIALS WITH ENHANCED PERFORMANCE AND SAFETY 5/5 5/5 0/5 0/5 Wata K-100 KL-140/2 .5-RAN Kit-12015.0 FIG. 32 1-1 N 1-1 N 00 1-1 00 1-1 O C (57) : The present invention relates to an antimicrobial pharmaceutical composition, comprising an aqueous carrier; and an antimicrobial synthetic cationic polypeptide(s) dispersed in the aqueous carrier at a concentration in the range of about 0.01% to about 5%, by weight based on total weight of the antimicrobial pharmaceutical composition, wherein the antimicrobial synthetic cationic polypeptide(s) comprises a plurality of positively charged amino acid units at neutral pH, and fulfils certain viscosity and toxicity requirements. The invention further relates to a method of preventing microbial contamination of tissues other than intact, healthy skin, comprising administering the present antimicrobial pharmaceutical composition in an amount effective to at least partially protect the tissue site from becoming contaminated with microbes. [Continued on next page] WO 2018/187617 Al MIDEDIM01101 DIDIMMIN0MMEIHR1111111111111111111111111111 TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: — with international search report (Art. 21(3))
SG11201909016T 2017-04-06 2018-04-05 Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety SG11201909016TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762482630P 2017-04-06 2017-04-06
PCT/US2018/026322 WO2018187617A1 (en) 2017-04-06 2018-04-05 Compositions and uses of locally applied antimicrobials with enhanced performance and safety

Publications (1)

Publication Number Publication Date
SG11201909016TA true SG11201909016TA (en) 2019-10-30

Family

ID=63712780

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201909016T SG11201909016TA (en) 2017-04-06 2018-04-05 Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety

Country Status (11)

Country Link
US (2) US11285189B2 (en)
EP (1) EP3606543A4 (en)
JP (2) JP2020513016A (en)
KR (2) KR20240135875A (en)
CN (1) CN110740744A (en)
AU (2) AU2018249552A1 (en)
BR (1) BR112019020781A2 (en)
CA (1) CA3058901A1 (en)
MX (1) MX2022007904A (en)
SG (1) SG11201909016TA (en)
WO (1) WO2018187617A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2867903C (en) 2012-03-23 2023-02-14 Amicrobe, Inc. Compositions and uses of antimicrobial materials with tissue-compatible properties
AU2018249552A1 (en) 2017-04-06 2019-10-31 Amicrobe, Inc. Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety
WO2021092382A1 (en) 2019-11-08 2021-05-14 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Compositions comprising antimicrobial peptides
EP4125995A4 (en) * 2020-03-31 2024-04-10 3-D Matrix, Ltd. Sterilization of self-assembling peptides by irradiation
KR20220166832A (en) * 2020-04-08 2022-12-19 아미크로베, 인코포레이티드. Compositions and Uses of Topically Applied Synthetic Amino Acid Polymers for Prevention and Treatment of Viral Infections

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5636643A (en) 1991-11-14 1997-06-10 Wake Forest University Wound treatment employing reduced pressure
US6680365B1 (en) 1998-03-19 2004-01-20 The Regents Of The University Of California Methods and compositions for controlled polypeptide synthesis
US6686446B2 (en) 1998-03-19 2004-02-03 The Regents Of The University Of California Methods and compositions for controlled polypeptide synthesis
US6632922B1 (en) 1998-03-19 2003-10-14 The Regents Of The University Of California Methods and compositions for controlled polypeptide synthesis
TW570805B (en) 1998-09-01 2004-01-11 Hoffmann La Roche Water-soluble pharmaceutical composition in an ionic complex
JP2002537102A (en) 1999-02-26 2002-11-05 カイロン コーポレイション Microemulsion with adsorbed polymer and fine particles
JP2004518631A (en) 2000-09-28 2004-06-24 カイロン コーポレイション Microparticles for delivery of heterologous nucleic acids
US6835536B2 (en) * 2001-08-21 2004-12-28 Micrologix Biotech Inc. Antimicrobial cationic peptides and formulations thereof
US6818732B2 (en) 2001-08-30 2004-11-16 The Regents Of The University Of California Transition metal initiators for controlled poly (beta-peptide) synthesis from beta-lactam monomers
JP2003171463A (en) * 2001-12-06 2003-06-20 Chisso Corp Polylysine and method for producing the same
KR20040080923A (en) 2002-02-07 2004-09-20 가부시키가이샤 오프테꾸스 Contact lenses solution
KR20200083657A (en) 2002-12-09 2020-07-08 아브락시스 바이오사이언스, 엘엘씨 Compositions and methods of delivery of pharmacological agents
DE602004012269T2 (en) 2003-07-11 2009-04-30 Theravance, Inc., South San Francisco CROSS-LINKED GLYCOPEPTIDE-CEPHALOSPORIN ANTIBIOTICS
WO2005018701A1 (en) 2003-08-25 2005-03-03 Kane Biotech Inc. Synergistic antimicrobial compositions and methods of inhibiting biofilm formation
US20080019955A1 (en) 2003-12-30 2008-01-24 Bioactive Polymers Ab Surface Protection of Exposed Biological Tissues
EP1987843A3 (en) * 2004-03-12 2011-10-26 Intercell AG Method for solubilising peptide mixtures
EP1927597B1 (en) 2004-08-18 2016-11-02 Novabiotics Limited Antibacterial peptides
RU2415150C2 (en) 2005-06-06 2011-03-27 Новозимс Эдениум Байотек А/С Polypeptides exhibiting antimicrobial activity and coding polynucleotides
US20080139450A1 (en) 2005-07-01 2008-06-12 Srinivasa Madhyastha Antimicrobial Compositions and Uses Thereof
WO2007095005A1 (en) 2006-02-10 2007-08-23 Z-Medica Corporation Agents and devices for providing blood clotting functions to wounds
CA2671461C (en) 2006-12-01 2014-01-28 The Regents Of The University Of California Vesicles of self-assembling block copolymers and methods for making and using the same
CA2691645A1 (en) 2007-06-25 2008-12-31 Lipopeptide Ab New medical products
JP2010537997A (en) 2007-08-27 2010-12-09 マサチューセッツ インスティテュート オブ テクノロジー Influenza virus inhibitors conjugated to bifunctional polymers
CA2727428A1 (en) 2008-06-19 2009-12-23 Nippon Shinyaku Co., Ltd. Drug carrier
DK2349310T3 (en) 2008-10-20 2014-08-11 Moerae Matrix Inc POLYPEPTIME FOR TREATMENT OR PREVENTION OF ADHESIONS
JP5752051B2 (en) 2009-01-23 2015-07-22 ケーン バイオテク インコーポレーテッド Antibacterial composition for biofilm removal and use thereof
GB0905451D0 (en) 2009-03-31 2009-05-13 Novabiotics Ltd Biofilms
US9534223B2 (en) 2010-04-27 2017-01-03 Lysando Ag Method of reducing biofilms
PL2608800T3 (en) * 2010-08-23 2017-08-31 Amicrobe Inc Compositions and uses of materials with high antimicrobial activity and low toxicity
JP5613779B2 (en) 2011-01-19 2014-10-29 株式会社メニコン Contact lens solution
US9781949B2 (en) 2011-03-31 2017-10-10 The University Of Massachusetts Antimicrobial delivery systems, methods of manufacture, and methods of use thereof
CA2867903C (en) * 2012-03-23 2023-02-14 Amicrobe, Inc. Compositions and uses of antimicrobial materials with tissue-compatible properties
DE102014101663A1 (en) 2014-02-11 2015-08-13 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Synthetic artificial peptides with antimicrobial activity
WO2016044683A1 (en) 2014-09-19 2016-03-24 Tensive Controls, Inc. Anti-microbial peptides
AU2015338969B2 (en) * 2014-10-30 2020-08-27 Biomet Manufacturing, Llc Methods of preventing surgical site infections
JP2016113373A (en) * 2014-12-11 2016-06-23 エスポ化学株式会社 Water-soluble composition having antibacterial and antiviral properties
AU2018249552A1 (en) * 2017-04-06 2019-10-31 Amicrobe, Inc. Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety
WO2019169324A1 (en) 2018-03-02 2019-09-06 January Therapeutics, Inc. Nanoparticle compositions

Also Published As

Publication number Publication date
JP2020513016A (en) 2020-04-30
KR20240135875A (en) 2024-09-12
BR112019020781A2 (en) 2020-04-28
CA3058901A1 (en) 2018-10-11
EP3606543A1 (en) 2020-02-12
MX2022007904A (en) 2022-07-21
RU2019133628A3 (en) 2021-07-14
US11285189B2 (en) 2022-03-29
CN110740744A (en) 2020-01-31
JP2023054375A (en) 2023-04-13
AU2023202283A1 (en) 2023-05-11
WO2018187617A8 (en) 2019-10-17
WO2018187617A1 (en) 2018-10-11
AU2018249552A1 (en) 2019-10-31
KR20200018400A (en) 2020-02-19
EP3606543A4 (en) 2020-12-16
US20210100867A1 (en) 2021-04-08
RU2019133628A (en) 2021-05-06
US20230017994A1 (en) 2023-01-19

Similar Documents

Publication Publication Date Title
SG11201909016TA (en) Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety
SG11201908420WA (en) Compositions of plinabulin and use thereof
SG11201908560SA (en) Heterocyclic compounds useful as dual atx/ca inhibitors
SG11201900596XA (en) Cannabis composition
SG11201809751XA (en) Egfr inhibitor compounds
SG11201908330PA (en) Farnesoid x receptor agonists and uses thereof
SG11201907604UA (en) Crystalline forms of the 4-pyrimidinesulfamide derivative aprocitentan
SG11201908547VA (en) Hydrogel cross-linked hyaluronic acid prodrug compositions and methods
SG11201809082WA (en) Nlrp3 modulators
SG11201907742YA (en) Pharmaceutical compositions of a bile acid derivative and microbiome and uses thereof
SG11201811490XA (en) Cd3 binding antibodies
SG11201906885TA (en) Methods for the administration of certain vmat2 inhibitors
SG11201907544VA (en) Jak inhibitors containing a 4-membered heterocyclic amide
SG11201908179UA (en) Aryl cyclopropyl-amino-isoquinolinyl amide compounds
SG11201900501RA (en) Cannabis composition
SG11201907023UA (en) Method of reducing neutropenia
SG11201408173WA (en) Pyrimidinyl tyrosine kinase inhibitors
CA3025288C (en) Reduced misting alkaline and neutral cleaning, sanitizing, and disinfecting compositions via the use of high molecular weight water-in-oil emulsion polymers
SG11201908512YA (en) Somatostatin modulators and uses thereof
SG11201806583XA (en) Compositions containing tucaresol or its analogs
SG11201900554YA (en) Spiro-lactam nmda modulators and methods of using same
SG11201906436VA (en) Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
SG11201808106YA (en) Use of masitinib for treatment of an amyotrophic lateral sclerosis patient subpopulation
SG11201901534VA (en) Combination therapy with controlled-release cnp agonists
SG11201900551WA (en) Spiro-lactam nmda receptor modulators and uses thereof